Patents by Inventor Rhys Salter

Rhys Salter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES TO QUETIAPINE AND USE THEREOF
    Publication number: 20170176474
    Abstract: Disclosed is an antibody or a binding fragment thereof which binds to quetiapine, which can be used to detect quetiapine in a sample such as in a competitive immunoassay method. The antibody or the fragment thereof can be used in a lateral flow assay device for point-of-care detection of quetiapine, including multiplex detection of aripiprazole, quetiapine, olanzapine, and risperidone in a single lateral flow assay device.
    Type: Application
    Filed: December 15, 2016
    Publication date: June 22, 2017
    Applicant: Janssen Pharmaceutica NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew G. Donahue, Yong Gong
  • SUBSTITUTED PYRIDINE DERIVATIVES USEFUL AS C-FMS KINASE INHIBITORS
    Publication number: 20170158678
    Abstract: The present invention is directed to substituted pyridine derivatives, pharmaceutical compositions containing said derivatives and the use of said derivatives in the treatment of disorders mediated by c-fms kinase. The present invention is further directed to a process for the preparation of said substituted pyridine derivatives.
    Type: Application
    Filed: February 23, 2017
    Publication date: June 8, 2017
    Inventors: Jie CHEN, Matthew DONAHUE, Heng-Keang LIM, Ronghui LIN, Rhys SALTER, Jiejun WU, Yong GONG
  • Substituted pyridine derivatives useful as C-FMS kinase inhibitors
    Patent number: 9611259
    Abstract: The present invention is directed to substituted pyridine derivatives, pharmaceutical compositions containing said derivatives and the use of said derivatives in the treatment of disorders mediated by c-fms kinase. The present invention is further directed to a process for the preparation of said substituted pyridine derivatives.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: April 4, 2017
    Assignee: Janssen Pharmaceutica NV
    Inventors: Jie Chen, Matthew Donahue, Heng-Keang Lim, Ronghui Lin, Rhys Salter, Jiejun Wu, Yong Gong
  • Antibodies to aripiprazole haptens and use thereof
    Patent number: 9611332
    Abstract: Disclosed is an antibody which binds to aripiprazole, which can be used to detect aripiprazole in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of aripiprazole, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: April 4, 2017
    Assignee: Janssen Pharmaceutica NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M Remmerie, Rhys Salter, Ronghui Lin
  • HAPTENS OF ARIPIPRAZOLE
    Publication number: 20170072061
    Abstract: The invention relates to compounds of Formula I, wherein R1, R2, and R3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from aripiprazole. The invention also relates to conjugates of an aripiprazole hapten and a protein.
    Type: Application
    Filed: November 3, 2016
    Publication date: March 16, 2017
    Applicant: Janssen Pharmaceutica NV
    Inventors: Ronghui Lin, Rhys Salter, Thomas R. Decory, Eric Hryhorenko, Bart M. Remmerie, Banumathi Sankaran
  • ANTIBODIES TO OLANZAPINE AND USE THEREOF
    Publication number: 20170037152
    Abstract: Disclosed is an antibody which binds to olanzapine, which can be used to detect olanzapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of olanzapine, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
    Type: Application
    Filed: October 20, 2016
    Publication date: February 9, 2017
    Applicant: Janssen Pharmaceutica NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew G. Donahue, Yong Gong
  • ANTIBODIES TO ARIPIPRAZOLE AND USE THEREOF
    Publication number: 20170030936
    Abstract: Disclosed is an antibody which binds to aripiprazole, which can be used to detect aripiprazole in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of aripiprazole, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
    Type: Application
    Filed: October 17, 2016
    Publication date: February 2, 2017
    Applicant: Janssen Pharmaceutica NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Ronghui Lin
  • Haptens of aripiprazole
    Patent number: 9504682
    Abstract: The invention relates to compounds of Formula I, wherein R1, R2, and R3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from aripiprazole. The invention also relates to conjugates of an aripiprazole hapten and a protein.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: November 29, 2016
    Assignee: Janssen Pharmaceutica NV
    Inventors: Ronghui Lin, Rhys Salter, Thomas R. DeCory, Eric Hryhorenko, Bart Remmerie, Banumathi Sankaran
  • ANTIBODIES TO QUETIAPINE AND USE THEREOF
    Publication number: 20160341749
    Abstract: Disclosed is an antibody which binds to quetiapine, which can be used to detect quetiapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of quetiapine, including multiplex detection of aripiprazole, quetiapine, olanzapine, and risperidone in a single lateral flow assay device.
    Type: Application
    Filed: August 5, 2016
    Publication date: November 24, 2016
    Applicants: Janssen Pharmaceutica NV, Ortho-Clinical Diagnostics, Inc.
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. Decory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew G. Donahue, Yong Gong
  • Antibodies to aripiprazole and use thereof
    Patent number: 9494607
    Abstract: Disclosed is an antibody which binds to aripiprazole, which can be used to detect aripiprazole in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of aripiprazole, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: November 15, 2016
    Assignee: Janssen Pharmaceutica NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Ronghui Lin
  • Antibodies to olanzapine and use thereof
    Patent number: 9494608
    Abstract: Disclosed is an antibody which binds to olanzapine, which can be used to detect olanzapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of olanzapine, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: November 15, 2016
    Assignee: Janssen Pharmaceutica NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew Garrett Donahue, Yong Gong
  • Antibodies to quetiapine and use thereof
    Patent number: 9410972
    Abstract: Disclosed is an antibody which binds to quetiapine, which can be used to detect quetiapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of quetiapine, including multiplex detection of aripiprazole, quetiapine, olanzapine, and risperidone in a single lateral flow assay device.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: August 9, 2016
    Assignees: Janssen Pharmaceutica NV, Ortho-Clinical Diagnostics, Inc.
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew Garrett Donahue, Yong Gong
  • Haptens of olanzapine
    Patent number: 9303041
    Abstract: The invention relates to compounds of Formula I, wherein R1, R2, and R3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from olanzapine. The invention also relates to conjugates of an olanzapine hapten and a protein.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: April 5, 2016
    Assignees: Janssen Pharmaceutica NV, Ortho-Clinical Diagnostics, Inc.
    Inventors: Matthew Garrett Donahue, Yong Gong, Rhys Salter, Eric Hryhorenko, Thomas R. DeCory, Bart Remmerie, Banumathi Sankaran
  • Haptens of quetiapine
    Patent number: 9304126
    Abstract: The invention relates to compounds of Formula I, wherein R1, R2, and R3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from quetiapine. The invention also relates to conjugates of a quetiapine hapten and a protein.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: April 5, 2016
    Assignees: Janssen Pharmaceutica NV, Ortho-Clinical Diagnostics, Inc.
    Inventors: Matthew Garrett Donahue, Yong Gong, Rhys Salter, Eric Hryhorenko, Thomas R. DeCory, Bart Remmerie, Banumathi Sankaran
  • SUBSTITUTED PYRIDINE DERIVATIVES USEFUL AS C-FMS KINASE INHIBITORS
    Publication number: 20160016942
    Abstract: The present invention is directed to substituted pyridine derivatives, pharmaceutical compositions containing said derivatives and the use of said derivatives in the treatment of disorders mediated by c-fms kinase. The present invention is further directed to a process for the preparation of said substituted pyridine derivatives.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 21, 2016
    Inventors: Jie CHEN, Matthew DONAHUE, Heng-Keeng LIM, Ronghui LIN, Rhys SALTER, Jiejun WU
  • HAPTENS OF QUETIAPINE
    Publication number: 20140221616
    Abstract: The invention relates to compounds of Formula I, wherein R1, R2, and R3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from quetiapine. The invention also relates to conjugates of a quetiapine hapten and a protein.
    Type: Application
    Filed: August 20, 2013
    Publication date: August 7, 2014
    Applicants: Ortho-Clinical Diagnostics, Inc., Janssen Pharmaceutica NV
    Inventors: Matthew Garrett DONAHUE, Yong Gong, Rhys Salter, Eric Hryhorenko, Thomas R. DeCory, Bart Remmerie, Banumathi Sankaran
  • HAPTENS OF OLANZIPINE
    Publication number: 20140213766
    Abstract: The invention relates to compounds of Formula I, wherein R1, R2, and R3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from olanzipine. The invention also relates to conjugates of an olanzipine hapten and a protein.
    Type: Application
    Filed: August 20, 2013
    Publication date: July 31, 2014
    Applicants: Ortho-Clinical Diagnostics, Inc., JANSSEN PHARMACEUTICA NV
    Inventors: Matthew Garrett DONAHUE, Yong GONG, Rhys SALTER, Eric HRYHORENKO, Thomas R. DeCORY, Bart REMMERIE, Banumathi SANKARAN
  • HAPTENS OF ARIPIPRAZOLE
    Publication number: 20140163206
    Abstract: The invention relates to compounds of Formula I, wherein R1, R2, and R3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from aripiprazole. The invention also relates to conjugates of an aripiprazole hapten and a protein.
    Type: Application
    Filed: August 20, 2013
    Publication date: June 12, 2014
    Applicants: Ortho-Clinical Diagnostics, Inc., JANSSEN PHARMACEUTICA NV
    Inventors: Ronghui LIN, Rhys SALTER, Thomas R. DeCORY, Eric HRYHORENKO, Bart REMMERIE, Banumathi SANKARAN
  • Antibodies to Aripiprazole and Use Thereof
    Publication number: 20140057300
    Abstract: Disclosed is an antibody which binds to aripiprazole, which can be used to detect aripiprazole in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of aripiprazole, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
    Type: Application
    Filed: August 20, 2013
    Publication date: February 27, 2014
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Ronghui Lin
  • Antibodies to Olanzapine Haptens and Use Thereof
    Publication number: 20140057303
    Abstract: Disclosed is an antibody which binds to olanzapine, which can be used to detect olanzapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of olanzapine, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
    Type: Application
    Filed: August 20, 2013
    Publication date: February 27, 2014
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew Garrett Donahue, Yong Gong